Geriatric characteristics in randomised controlled trials on antidepressant drugs for older adults: a systematic review. (Q38753966)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924120%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Geriatric characteristics in randomised controlled trials on antidepressant drugs for older adults: a systematic review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924120%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Carolien E M Benraad

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924120%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Floor Kamerman-Celie

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924120%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Barbara C van Munster

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924120%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Jan Spijker

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924120%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

language of work or name

English

0 references

publication date

28 February 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924120%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Geriatric Psychiatry

9 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924120%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924120%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924120%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

990-1003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924120%20AND%20SRC:MED&resulttype=core&format=json

Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram

9 March 2020

cites work

1 reference

Treatment response in late-onset depression: relationship to neuropsychological, neuroradiological and vascular risk factors.

21 January 2018

1 reference

Review of community prevalence of depression in later life

21 January 2018

1 reference

Physical functioning in older persons with somatoform disorders: a pilot study.

21 January 2018

1 reference

Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life.

21 January 2018

1 reference

Escitalopram in the acute treatment of depressed patients aged 60 years or older

21 January 2018

1 reference

Antidepressants in elderly: metaregression of double-blind, randomized clinical trials

21 January 2018

1 reference

Clinical features and efficacy of escitalopram treatment for geriatric depression

21 January 2018

1 reference

Frailty in elderly people

21 January 2018

1 reference

Risk factors for depression among elderly community subjects: a systematic review and meta-analysis

21 January 2018

1 reference

Physical frailty: vulnerability of patients suffering from late-life depression

21 January 2018

1 reference

Depression and body mass index, a u-shaped association

21 January 2018

1 reference

Prevalence and predictors of depression in populations of elderly: a review

21 January 2018

1 reference

Frailty predicts new and persistent depressive symptoms among community-dwelling older adults: findings from Singapore longitudinal aging study

21 January 2018

1 reference

A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.

21 January 2018

1 reference

Single-blind comparison of venlafaxine and nortriptyline in elderly major depression

21 January 2018

1 reference

Clinical trials of potential antidepressants: to what extent are the elderly represented: a review

21 January 2018

1 reference

A rating scale for depression

21 January 2018

1 reference

Design characteristics that influence attrition in geriatric antidepressant trials: meta-analysis

21 January 2018

1 reference

The efficacy of agomelatine in elderly patients with recurrent major depressive disorder: a placebo-controlled study

21 January 2018

1 reference

Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorder

21 January 2018

1 reference

Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept.

21 January 2018

1 reference

Collaborative care for patients with depression and chronic illnesses

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder

21 January 2018

1 reference

Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial.

21 January 2018

1 reference

Efficacy of treatment in older depressed patients: a systematic review and meta-analysis of double-blind randomized controlled trials with antidepressants.

21 January 2018

1 reference

Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology

21 January 2018

1 reference

Moderation of antidepressant and placebo outcomes by baseline severity in late-life depression: A systematic review and meta-analysis.

21 January 2018

1 reference

Age- and gender-specific prevalence of depression in latest-life--systematic review and meta-analysis.

21 January 2018

1 reference

Improving recruitment of older people to research through good practice

21 January 2018

1 reference

Are depression and frailty overlapping syndromes in mid- and late-life? A latent variable analysis

21 January 2018

1 reference

Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale

21 January 2018

1 reference

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

Citalopram versus nortriptyline in late-life depression: a 12-week randomized single-blind study

21 January 2018

1 reference

Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence

21 January 2018

1 reference

Association between medical comorbidity and treatment outcomes in late-life depression

21 January 2018

1 reference

Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile

21 January 2018

1 reference

Goal-oriented patient care--an alternative health outcomes paradigm

21 January 2018

1 reference

Acute and long-term treatment of late-life major depressive disorder: duloxetine versus placebo

21 January 2018

1 reference

Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial

21 January 2018

1 reference

Clinic visits in late-life depression trials: effects on signal detection and therapeutic outcome

21 January 2018

1 reference

Malnutrition in the elderly and its relationship with other geriatric syndromes

21 January 2018

1 reference

Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients

21 January 2018

1 reference

An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression

21 January 2018

1 reference

Efficacy, safety, and tolerability of sertraline in patients with late-life depression and comorbid medical illness

21 January 2018

1 reference

Determinants of non-compliance and attrition in the elderly

21 January 2018

1 reference

The vascular depression hypothesis: mechanisms linking vascular disease with depression

21 January 2018

1 reference

White Matter Hyperintensity Progression and Late-Life Depression Outcomes

21 January 2018

1 reference

Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials

21 January 2018

1 reference

Somatic symptom overlap in Beck Depression Inventory-II scores following myocardial infarction

21 January 2018

1 reference

Comparative efficacy and safety of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors in older adults: a network meta-analysis

21 January 2018

1 reference

A double-blind, randomized, 26-week study comparing the cognitive and psychomotor effects and efficacy of 75 mg (37.5 mg b.i.d.) venlafaxine and 75 mg (25 mg mane, 50 mg nocte) dothiepin in elderly patients with moderate major depression being treat

21 January 2018

1 reference

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

The safety and tolerability of duloxetine in depressed elderly patients with and without medical comorbidity

21 January 2018

1 reference

Duloxetine for the treatment of recurrent major depressive disorder in elderly patients: treatment outcomes in patients with comorbid arthritis

21 January 2018

1 reference

Depression and physical health in later life: results from the Longitudinal Aging Study Amsterdam (LASA)

21 January 2018

1 reference

7 January 2021

Antidepressant efficacy and safety of low-dose sertraline and standard-dose imipramine for the treatment of depression in older adults: results from a double-blind, randomized, controlled clinical trial

1 reference

7 January 2021

Depression in medically ill hospitalized older adults: prevalence, characteristics, and course of symptoms according to six diagnostic schemes

1 reference

7 January 2021

The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients

1 reference

7 January 2021

The PRECIS-2 tool: designing trials that are fit for purpose

1 reference

7 January 2021

A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients

1 reference

7 January 2021

Low doses of controlled-release paroxetine in the treatment of late-life depression: a randomized, placebo-controlled trial.

1 reference

7 January 2021

Efficacy of controlled-release paroxetine in the treatment of late-life depression.

1 reference

7 January 2021

A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression

1 reference

7 January 2021

The measurement of disability.

1 reference

7 January 2021

Why the exclusion of older people from clinical research must stop

1 reference

7 January 2021

Identifiers

DOI

10.1002/GPS.4443

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924120%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924120%20AND%20SRC:MED&resulttype=core&format=json